X4 Pharmaceuticals, Inc. (XFOR) Ownership

$3.52

$0.27 (8.31%)
Last update: 04:00 PM EST
Day's range
$3.25
Day's range
$3.56

X4 Pharmaceuticals, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC 05/15/2025 16.92 M $4.00 M   0.00% 0.27%
NEA MANAGEMENT COMPANY, LLC 05/14/2025 14.99 M $3.54 M   0.00% 0.24%
BLACKROCK, INC. 05/02/2025 11.43 M $2.70 M   3.34% 0.19%
VANGUARD GROUP INC 05/09/2025 8.07 M $1.90 M   -1.63% 0.13%
05/19/2025 7.31 M $1.75 M   0.00% 0.12%
KINGDON CAPITAL MANAGEMENT, L.L.C. 05/15/2025 7.00 M $1.65 M   41.79% 0.11%
ORBIMED ADVISORS LLC 05/15/2025 6.78 M $1.60 M   -5.00% 0.11%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 3.62 M $855.79 K   3.50% 0.06%
STATE STREET CORP 05/15/2025 3.06 M $722.22 K   -0.07% 0.05%
ENSIGN PEAK ADVISORS, INC 05/14/2025 2.24 M $528.51 K   -12.21% 0.04%
PALE FIRE CAPITAL SE 05/14/2025 2.04 M $481.16 K   45.18% 0.03%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 1.71 M $404.80 K   -9.28% 0.03%
NORTHERN TRUST CORP 05/13/2025 1.25 M $296.40 K   -7.64% 0.02%
AXA S.A. 05/15/2025 691.12 K $163.38 K   -77.50% 0.01%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2025 650.00 K $153.66 K   0.00% 0.01%
MORGAN STANLEY 05/15/2025 570.01 K $134.75 K   3.55% 0.01%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 481.53 K $113.83 K   9.89% 0.01%
BANK OF NEW YORK MELLON CORP 04/29/2025 344.75 K $81.50 K   0.00% 0.01%
SCHONFELD STRATEGIC ADVISORS LLC 05/15/2025 335.44 K $79.30 K   -75.92% 0.01%
CITADEL ADVISORS LLC 05/15/2025 291.80 K $68.98 K   76.31% 0.00%
GOLDMAN SACHS GROUP INC 05/16/2025 273.87 K $64.74 K   -42.66% 0.00%
DEUTSCHE BANK AG\ 05/09/2025 267.63 K $64.23 K   0.00% 0.00%
MILLENNIUM MANAGEMENT LLC 05/15/2025 258.76 K $61.17 K   0.00% 0.00%
UBS OCONNOR LLC 05/15/2025 252.60 K $59.61 K   -80.02% 0.00%
RHUMBLINE ADVISERS 05/29/2025 188.42 K $44.45 K   5.42% 0.00%
BARCLAYS PLC 05/15/2025 185.08 K $44.00 K   -30.46% 0.00%
GROUP ONE TRADING, L.P. 05/14/2025 172.11 K $40.69 K   -78.42% 0.00%
JPMORGAN CHASE & CO 05/12/2025 165.44 K $39.11 K   -64.01% 0.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 162.70 K $39.05 K   -30.32% 0.00%
CITIGROUP INC 05/12/2025 122.36 K $28.93 K   -10.82% 0.00%
SIMPLEX TRADING, LLC 05/12/2025 111.70 K $26.00 K   -41.79% 0.00%
ALLIANCEBERNSTEIN L.P. 05/15/2025 109.57 K $25.90 K   0.00% 0.00%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 05/15/2025 100.69 K $23.80 K   4.46% 0.00%
SG AMERICAS SECURITIES, LLC 04/15/2025 91.49 K $22.00 K   -50.05% 0.00%
AQR CAPITAL MANAGEMENT LLC 05/15/2025 86.96 K $20.56 K   224.02% 0.00%
COREBRIDGE FINANCIAL, INC. 05/14/2025 83.60 K $19.76 K   0.07% 0.00%
WELLS FARGO & COMPANY/MN 05/13/2025 81.54 K $19.28 K   3.84% 0.00%
BANK OF AMERICA CORP /DE/ 05/15/2025 77.34 K $18.25 K   -42.07% 0.00%
STIFEL FINANCIAL CORP 05/14/2025 75.55 K $17.86 K   -0.08% 0.00%
VIRTU FINANCIAL LLC 05/12/2025 67.31 K $16.00 K   100.00% 0.00%
CIBC PRIVATE WEALTH GROUP, LLC 05/14/2025 64.99 K $13.79 K   100.00% 0.00%
VOYA INVESTMENT MANAGEMENT LLC 05/15/2025 59.32 K $14.02 K   1.06% 0.00%
INVESCO LTD. 05/12/2025 58.19 K $13.76 K   -6.26% 0.00%
INTECH INVESTMENT MANAGEMENT LLC 05/20/2025 57.96 K $13.70 K   100.00% 0.00%
XTX TOPCO LTD 05/08/2025 57.80 K $13.67 K   100.00% 0.00%
NEW YORK STATE COMMON RETIREMENT FUND 05/01/2025 51.64 K $12.00 K   0.00% 0.00%
TD WATERHOUSE CANADA INC. 05/09/2025 45.00 K $9.81 K   0.00% 0.00%
NEUBERGER BERMAN GROUP LLC 05/13/2025 44.67 K $10.56 K   100.00% 0.00%
FMR LLC 05/12/2025 41.12 K $9.72 K   775.41% 0.00%
CANTOR FITZGERALD, L. P. 05/15/2025 40.25 K $9.52 K   0.00% 0.00%

X4 Pharmaceuticals, Inc. institutional Ownership - FAQ's

During the previous two years, 118 institutional investors and hedge funds held shares of X4 Pharmaceuticals, Inc.. The most heavily invested institutionals were:

Bain Capital Life Sciences Investors, LLC: 16.92 M

NEA Management Company, LLC: 14.99 M

BlackRock, Inc.: 11.43 M

VANGUARD GROUP INC: 8.07 M

KINGDON CAPITAL MANAGEMENT, L.L.C.: 7 M

ORBIMED ADVISORS LLC: 6.78 M

1.60% of X4 Pharmaceuticals, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 97.84 M shares in the last 24 months. This purchase volume represents approximately $344.40 M in transactions.